Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 21;25(6):433-447.
doi: 10.1093/ijnp/pyac009.

Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review

Affiliations

Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review

Nathan T M Huneke et al. Int J Neuropsychopharmacol. .

Abstract

Background: The mechanisms underlying placebo effects of psychotropic drugs remain poorly understood. We carried out the first, to our knowledge, systematic review of functional neuroimaging correlates of placebo response in adults with anxiety/depressive disorders.

Methods: We systematically searched a large set of databases up to February 2021 based on a pre-registered protocol (PROSPERO CRD42019156911). We extracted neuroimaging data related to clinical improvement following placebo or related to placebo mechanisms. We did not perform a meta-analysis due to the small number of included studies and significant heterogeneity in study design and outcome measures.

Results: We found 12 relevant studies for depressive disorders and 4 for anxiety disorders. Activity in the ventral striatum, rostral anterior cingulate cortex and other default mode network regions, orbitofrontal cortex, and dorsolateral prefrontal cortex correlated with placebo antidepressant responses. Activity in regions of the default mode network, including posterior cingulate cortex, was associated with placebo anxiolysis. There was also evidence for possible involvement of the endogenous opioid, dopamine, and serotonin systems in placebo antidepressant and anxiolytic effects.

Conclusions: Several brain regions and molecular systems may be involved in these placebo effects. Further adequately powered studies exploring causality and controlling for confounders are required.

Keywords: Placebo response; anxiety; depression; functional neuroimaging.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study selection flow diagram.
Figure 2.
Figure 2.
Traffic light plot summarizing review authors’ judgements regarding risk of bias for each included study.
Figure 3.
Figure 3.
Plot showing review authors’ judgements regarding risk of bias by percentage.

References

    1. Ashar YK, Chang LJ, Wager TD (2017) Brain mechanisms of the placebo effect: an affective appraisal account. Annu Rev Clin Psychol 13:73–98. - PubMed
    1. Atlas LY, Wager TD(2014) A Meta-analysis of brain mechanisms of placebo analgesia: consistent findings and unanswered questions. In: Placebo (Benedetti F, Enck P, Frisaldi E, Schedlowski M, eds), pp 37–69. Berlin, Heidelberg: Springer Berlin Heidelberg. - PMC - PubMed
    1. Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D (2015) Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 30:183–192. - PubMed
    1. Benedetti F, Carlino E, Pollo A (2011) How placebos change the patient’s brain. Neuropsychopharmacology 36:339–354. - PMC - PubMed
    1. Chin Fatt CR, Jha MK, Cooper CM, Fonzo G, South C, Grannemann B, Carmody T, Greer TL, Kurian B, Fava M, McGrath PJ, Adams P, McInnis M, Parsey RV, Weissman M, Phillips ML, Etkin A, Trivedi MH (2020) Effect of intrinsic patterns of functional brain connectivity in moderating antidepressant treatment response in major depression. Am J Psychiatry 177:143–154. - PubMed

Publication types

Substances